A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2.

IF 1 4区 医学 Q3 OTORHINOLARYNGOLOGY
Andi Abeshi, Gian Gaetano Ferri
{"title":"A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2.","authors":"Andi Abeshi,&nbsp;Gian Gaetano Ferri","doi":"10.5152/iao.2023.22922","DOIUrl":null,"url":null,"abstract":"<p><p>Bilateral vestibular schwannomas are commonly diagnosed in patients affected by neurofibromatosis type 2, a genetic disease caused by a heterozygous mutation in the gene region encoding neurofibromin-2. Sporadic bilateral vestibular schwannomas are very rare entities affecting almost exclusively elderly people. We present the case of a senior woman who was followed up with the \"wait-and-scan\" strategy for a unilateral vestibular schwannoma that later developed as a contralateral tumor, compatible with vestibular schwannoma, raising questions about its nature and risk of having been transmitted in offspring. Genetic testing excluded mutations of the neurofibromatosis type 2 gene. The presence of bilateral vestibular schwannomas is often considered pathognomonic of neurofibromatosis type 2, but the estimated probability of sporadic bilateral tumors in the absence of other neurofibromatosis type 2 features is 50% over 70 years of age. Therefore, the NF2 gene assessment is in any case recommended in these patients not only for an evaluation of the risk of being transmitted. The treatment strategy should be carefully personalized for each patient, considering the size of the tumors, symptoms, and hearing function together with the patient's age.</p>","PeriodicalId":54793,"journal":{"name":"Journal of International Advanced Otology","volume":"19 3","pages":"263-265"},"PeriodicalIF":1.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/0e/jiao-19-3-263.PMC10331633.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Advanced Otology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/iao.2023.22922","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Bilateral vestibular schwannomas are commonly diagnosed in patients affected by neurofibromatosis type 2, a genetic disease caused by a heterozygous mutation in the gene region encoding neurofibromin-2. Sporadic bilateral vestibular schwannomas are very rare entities affecting almost exclusively elderly people. We present the case of a senior woman who was followed up with the "wait-and-scan" strategy for a unilateral vestibular schwannoma that later developed as a contralateral tumor, compatible with vestibular schwannoma, raising questions about its nature and risk of having been transmitted in offspring. Genetic testing excluded mutations of the neurofibromatosis type 2 gene. The presence of bilateral vestibular schwannomas is often considered pathognomonic of neurofibromatosis type 2, but the estimated probability of sporadic bilateral tumors in the absence of other neurofibromatosis type 2 features is 50% over 70 years of age. Therefore, the NF2 gene assessment is in any case recommended in these patients not only for an evaluation of the risk of being transmitted. The treatment strategy should be carefully personalized for each patient, considering the size of the tumors, symptoms, and hearing function together with the patient's age.

Abstract Image

Abstract Image

Abstract Image

双侧前庭神经鞘瘤并不总是与2型神经纤维瘤病有关。
双侧前庭神经鞘瘤通常在2型神经纤维瘤病患者中诊断出来,2型神经纤维瘤病是一种由编码神经纤维蛋白-2基因区域的杂合突变引起的遗传性疾病。散发性双侧前庭神经鞘瘤非常罕见,几乎只影响老年人。我们报告了一位老年女性的病例,她的单侧前庭神经鞘瘤后来发展为对侧肿瘤,与前庭神经鞘瘤相容,对其性质和遗传给后代的风险提出了疑问。基因检测排除了2型神经纤维瘤病基因突变。双侧前庭神经鞘瘤的存在通常被认为是2型神经纤维瘤病的典型症状,但在没有其他2型神经纤维瘤病特征的情况下,估计70岁以上患者出现散发双侧肿瘤的概率为50%。因此,无论如何,推荐在这些患者中进行NF2基因评估,不仅是为了评估被传播的风险。考虑到肿瘤的大小、症状、听力功能以及患者的年龄,治疗策略应针对每位患者进行仔细的个性化治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
94
审稿时长
6-12 weeks
期刊介绍: The Journal of International Advanced Otology (IAO – Citation Abbreviation: J Int Adv Otol) is an open access double-blind peer-reviewed, international publication. The Journal of International Advanced Otology is fully sponsored and owned by the European Academy of Otology and Neurotology and the Politzer Society. The Journal of International Advanced Otology is published 3 times per year on April, August, December and its publication language is English. The scope of the Journal is limited with otology, neurotology, audiology (excluding linguistics) and skull base medicine. The Journal of International Advanced Otology aims to publish manuscripts at the highest clinical and scientific level. IAO publishes original articles in the form of clinical and basic research, review articles, short reports and a limited number of case reports. Controversial patient discussions, communications on emerging technology, and historical issues will also be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书